Study of the Effect of Lactisole on the Intestinal Glucose Uptake

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study of the effect of lactisole on glucose uptake

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Patients With Non-coeliac Gluten Sensitivity

NCT03798249

NCGS Gluten

UNKNOWN NA

Effect of Acute and Sub-acute Administration of Gluten on Extra-intestinal and Gastrointestinal Symptoms in Healthy Subjects

NCT03798262

Healthy Volunteers, Gluten

COMPLETED NA

Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo

NCT02472704

Celiac Disease Non-celiac Gluten Sensitivity

COMPLETED NA

A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free Diet

NCT05353985

Celiac Disease

COMPLETED PHASE2

Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study

NCT02936297

Non Celiac Gluten Sensitivity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

administration of lactisole

Group Type EXPERIMENTAL

lactisole

Intervention Type DIETARY_SUPPLEMENT

administration of lactisole followed by placebo

2

administration of placebo

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type OTHER

administration of placebo followed by lactisole

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

lactisole

administration of lactisole followed by placebo

Intervention Type DIETARY_SUPPLEMENT

placebo

administration of placebo followed by lactisole

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male subject, between 18 and 50 years
* General good health condition

Exclusion Criteria

* Overweight (Body Mass Index ≥30)
* Metabolic disorders
* History of gastrointestinal disorders
* Regular (daily) intake of medication
* Smoking more than 10 cigarettes/day
* History of drug abuse
* Exhaustive (\> 3 units/day) alcohol consumption
* Exhaustive (\> 5 units/day) caffeine consumption (coffee, tea, cola, or other caffeine based drinks)
* Recent (in the last 14 days) donation of blood
* Recent (in the last 2 days) donation of blood plasma
* Participation in another trial within 4 weeks before the start of the study

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes